Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sweden Recommends: A Dose of Northern Lights Therapy 2025-12-09 15:53
Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement Market 2025-12-09 10:30
Therme Group acquires full Thermengruppe Josef Wund portfolio through Therme Horizon, integrating all four Wund-origin destinations into its global platform 2025-12-09 09:00
Inheritance + Innovation + Development: The "Co-development" Path of Hakka Medicine and Traditional Chinese Medicine 2025-12-09 08:00
EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide 2025-12-09 03:11
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium 2025-12-09 03:05
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025 2025-12-08 22:22
PT Fapon and PT Bio Farma Forge Strategic Partnership to Advance IVD Localization and Innovation in Indonesia 2025-12-08 20:47
Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions 2025-12-08 20:24
Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight 2025-12-08 17:40
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder 2025-12-08 15:25
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others 2025-12-08 09:00
AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore 2025-12-08 08:00
RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION 2025-12-08 08:00
ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed 2025-12-08 06:08
/C O R R E C T I O N -- Seegene Inc./ 2025-12-06 00:00
AbbVie-Sponsored Symposium at ESMO Asia 2025 Highlights Urgent Medical Need in Platinum-Resistant Advanced Ovarian Cancer 2025-12-05 16:00
Agilent and Monash University Malaysia Mark 15-Year Partnership with New BioDiscovery Hub to Drive Regional Biotech Innovation 2025-12-05 09:30
Renuka Iyer, MD, Named New Chief Medical Officer for National Comprehensive Cancer Network (NCCN) 2025-12-04 21:04
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics 2025-12-04 19:50